Yang Z - Search Results

1

EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma.

Yuan L, Li S, Chen Q, Xia T, Luo D, Li L, Liu S, Guo S, Liu L, Du C, Jia G, Li X, Lu Z, Yang Z, Liu H, Mai H, Tang L. Yuan L, et al. Among authors: yang z. Cell Death Differ. 2022 Aug;29(8):1513-1527. doi: 10.1038/s41418-022-00939-8. Epub 2022 Feb 1. Cell Death Differ. 2022. PMID: 35105963 Free PMC article.

2

Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.

Liu SL, Sun XS, Li XY, Chen QY, Lin HX, Wen YF, Guo SS, Liu LT, Xie HJ, Tang QN, Liang YJ, Yan JJ, Lin C, Yang ZC, Tang LQ, Guo L, Mai HQ. Liu SL, et al. BMC Cancer. 2018 Dec 20;18(1):1279. doi: 10.1186/s12885-018-5192-x. BMC Cancer. 2018. PMID: 30572856 Free PMC article.

3

Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.

Liang YJ, Sun XS, Yang ZC, Tang QN, Guo SS, Liu LT, Xie HJ, Liu SL, Yan JJ, Li XY, Chen QY, Mai HQ. Liang YJ, et al. Oral Oncol. 2019 May;92:40-45. doi: 10.1016/j.oraloncology.2019.03.015. Epub 2019 Mar 19. Oral Oncol. 2019. PMID: 31010621

4

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.

Liu SL, Sun XS, Yan JJ, Chen QY, Lin HX, Wen YF, Guo SS, Liu LT, Xie HJ, Tang QN, Liang YJ, Li XY, Lin C, Du YY, Yang ZC, Xiao BB, Yang JH, Tang LQ, Guo L, Mai HQ. Liu SL, et al. Radiother Oncol. 2019 Aug;137:83-94. doi: 10.1016/j.radonc.2019.04.020. Epub 2019 May 9. Radiother Oncol. 2019. PMID: 31078941

5

The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis.

Wen YF, Sun XS, Yuan L, Zeng LS, Guo SS, Liu LT, Lin C, Xie HJ, Liu SL, Li XY, Zhang YB, Huang WJ, Peng HH, Liao ZW, Song XL, Tang QN, Liang YJ, Yan JJ, Yang JH, Yang ZC, Chen QY, Lin XD, Tang LQ, Mai HQ. Wen YF, et al. J Cancer. 2019 Sep 7;10(23):5614-5621. doi: 10.7150/jca.35311. eCollection 2019. J Cancer. 2019. PMID: 31737097 Free PMC article.

6

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.

Liu SL, Sun XS, Xie HJ, Chen QY, Lin HX, Liang H, Liang YJ, Li XY, Yan JJ, Lin C, Yang ZC, Guo SS, Liu LT, Tang QN, Du YY, Tang LQ, Guo L, Mai HQ. Liu SL, et al. BMC Cancer. 2020 Feb 3;20(1):89. doi: 10.1186/s12885-020-6555-7. BMC Cancer. 2020. PMID: 32013967 Free PMC article.

7

Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.

Liu LT, Liang YJ, Guo SS, Mo HY, Guo L, Wen YF, Xie HJ, Tang QN, Sun XS, Liu SL, Li XY, Yang JH, Yang ZC, Tang LQ, Chen QY, Mai HQ. Liu LT, et al. Ther Adv Med Oncol. 2020 Jun 2;12:1758835920928214. doi: 10.1177/1758835920928214. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32536983 Free PMC article.

8

Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.

Yan JJ, Guo SS, Lin DF, Liu LT, Liu SL, Xiao BB, Yang JH, Wen DX, Yang ZC, Liang YJ, Tang QN, Lin C, Li XY, Sun XS, Li JB, Tang LQ, Chen QY, Mai HQ. Yan JJ, et al. Radiother Oncol. 2021 Jul;160:9-17. doi: 10.1016/j.radonc.2021.03.040. Epub 2021 Apr 9. Radiother Oncol. 2021. PMID: 33839205 Free article.

9

Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.

Lu ZJ, Liu LT, Sun XS, Guo SS, Yang Q, Liu SL, Li XY, Qiu HZ, Yang ZC, Xiao BB, Lin C, Luo DH, Sun R, Lin HX, Chen QY, Tang LQ, Guo L, Mai HQ. Lu ZJ, et al. Radiother Oncol. 2021 Sep;162:202-211. doi: 10.1016/j.radonc.2021.03.035. Epub 2021 Apr 9. Radiother Oncol. 2021. PMID: 33839207 Clinical Trial.

10

Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy.

Yang ZC, Du CC, Liu T, Liu LT, Chen QY, Guo SS, Mai HQ. Yang ZC, et al. Head Neck. 2022 Jan;44(1):113-121. doi: 10.1002/hed.26899. Epub 2021 Oct 30. Head Neck. 2022. PMID: 34716739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45,523 results

Search Page